Literature DB >> 15829756

Intravitreal triamcinolone acetonide in serpiginous choroidopathy.

Avinash Pathengay.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15829756     DOI: 10.4103/0301-4738.15295

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


× No keyword cloud information.
  6 in total

1.  Steroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis).

Authors:  Baruch D Kuppermann; Leandro Cabral Zacharias; M Cristina Kenney
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

Review 2.  Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis.

Authors:  Hossein Nazari Khanamiri; Narsing A Rao
Journal:  Surv Ophthalmol       Date:  2013-03-27       Impact factor: 6.048

3.  Intravitreal triamcinolone for intraocular inflammation and associated macular edema.

Authors:  Steven M Couch; Sophie J Bakri
Journal:  Clin Ophthalmol       Date:  2009-06-02

4.  Manufacturing of Dexamethasone-Poly(d,l-Lactide-co-Glycolide) Implants Using Hot-Melt Extrusion: Within- and Between-Batch Product Performance Comparisons.

Authors:  Ryan A Kelley; Alireza Ghaffari; Yan Wang; Stephanie Choi; Jonathan R Taylor; Rachel R Hartman; Uday B Kompella
Journal:  J Ocul Pharmacol Ther       Date:  2020-04-24       Impact factor: 2.671

5.  Efficacy of reduced dose of intravitreal triamcinolone acetonide in a case of active serpiginous choroiditis.

Authors:  Avirupa Ghose; Promod S Bhende; Jyotirmoy Biswas
Journal:  Indian J Ophthalmol       Date:  2016-09       Impact factor: 1.848

Review 6.  Enigma of serpiginous choroiditis.

Authors:  Parthopratim Dutta Majumder; Jyotirmay Biswas; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2019-03       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.